ORIONPHARM 09-Jan-2020 The Company has informed that Ms. Zareen Karim has been appointed as the Managing Director of the Company.
ORIONPHARM 28-Nov-2019 Trading of the Shares of the Company will resume on 01.12.2019 after record date.
ORIONPHARM 27-Nov-2019 Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2019 for AGM and EGM.
ORIONPHARM 25-Nov-2019 Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 26.11.2019 to 27.11.2019. Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2019 for AGM and EGM.
ORIONPHARM 13-Nov-2019 (Q1 Un-audited): Consolidated EPS was Tk. 1.17 for July-September 2019 as against Tk. 0.98 for July-September 2018; Consolidated NOCFPS was Tk. 1.96 for July-September 2019 as against Tk. 2.62 for July-September 2018. Consolidated NAV per share (including revaluation surplus) was Tk. 76.33 as on September 30, 2019 and Tk. 75.19 as on June 30, 2019. Consolidated NAV per share (excluding revaluation surplus) was Tk. 68.15 as on September 30, 2019 and Tk. 66.98 as on June 30, 2019.
ORIONPHARM 07-Nov-2019 The Company has further informed that the EGM will be held on December 15, 2019 at 11:45 AM Venue: Officer's Club, 26 Baily Road, Ramna, Dhaka. Record Date: 28.11.2019. Other information will remain unchanged.
ORIONPHARM 07-Nov-2019 There will be no price limit on the trading of the shares of the Company today (07.11.2019) following its corporate declaration.
ORIONPHARM 07-Nov-2019 (Continuation news of ORIONPHARM): The Board has also advised to convene an EGM for changing Clause no. 115 of the Articles of Association of the Company and the proposal for approval of the shareholders regarding Related Party Transactions of OPL for the financial year ended on June 30, 2019. Date, Time, Venue and Record Date of the EGM will be notified later on. (end)
ORIONPHARM 07-Nov-2019 (Continuation news of ORIONPHARM): The Company has also reported Consolidated EPS of Tk. 3.77, Consolidated NAV per share (Including Revaluation Surplus) of Tk. 75.19, Consolidated NAV per share (Excluding Revaluation Surplus) of Tk. 66.98 and Consolidated NOCFPS of Tk. 6.19 for the year ended on June 30, 2019 as against Tk. 3.43, Tk. 72.88, Tk. 64.55 and Tk. 9.38 respectively for the same period of the previous year. (cont.2)
ORIONPHARM 07-Nov-2019 The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2019. Date of AGM: 15.12.2019, Time: 11:15 AM, Venue: Officer's Club, 26, Baily Road, Ramna, Dhaka. Record Date: 28.11.2019. (cont.1)